top of page

OMass Therapeutics CEO Ros Deegan on the company's "whole ecosystem" approach to drug discovery

She describes OMass' platform and rare disease focus, and also her thoughts on the UK ecosystem and what it means to participate on the Prime Minister's Business Council.



Komen


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page